anvisa

Monday, February 09, 2026

NEWS

anvisa

Brazil´s ANVISA authorizes monoclonal cocktail against Covid-19

Published on: April 21, 2021
07:39

Brasilia, Apr 21 (Prensa Latina) Brazil's National Health Regulatory Agency (ANVISA) unanimously approved on Tuesday the emergency use of the monoclonal antibodies cocktail against Covid-19, produced by Regeneron Company and marketed by Roche Pharmaceutical Company.

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

Radio – Publications – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado, Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division Prensa Latina.

anvisa

Brazil´s ANVISA authorizes monoclonal cocktail against Covid-19

LATEST NEWS